pyrroles has been researched along with Peripheral Nerve Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Feng, W; Guo, Z; He, K; Lin, D; Liu, J; Liu, W; Nie, L; Spencer, P; Wang, L; Yang, X; Yuan, J; Zhu, F | 1 |
| Aguirre-Valencia, D; Naranjo-Escobar, J; Navarro, EP; Posso-Osorio, I; Tobón, GJ | 1 |
| Li, M; Li, X; Wang, Q; Wang, S; Xie, K; Zhang, C | 1 |
| Almqvist, PM; Finnerup, NB; Gormsen, L; Jensen, TS | 1 |
| Ceresoli, GL; Colombo, P; De Sanctis, R; De Vincenzo, F; Gianoncelli, L; Graziotti, P; Lorenzi, E; Perrino, M; Santoro, A; Simonelli, M; Zucali, PA | 1 |
| Benemei, S; Creminon, C; Fusi, C; Geppetti, P; Materazzi, S; Nassini, R; Nilius, B; Patacchini, R; Pedretti, P; Prenen, J | 1 |
| Almenara, J; Alotaibi, M; Biggers, JW; Brown, R; Di, X; Emery, SM; Gewirtz, DA; Gupton, JT; Henderson, SC; Nguyen, T; White, KL | 1 |
| Backonja, MM; Dotson, RM; Dworkin, RH; Galer, BS; Katz, NP; Meisner, PD; Quessy, SN; Rauck, RL; Rowbotham, MC; Wallace, MS | 1 |
| Blackburn-Munro, G; Bomholt, SF; Erichsen, HK | 1 |
| Beeram, M; Berg, K; de Bono, JS; Eckhart, SG; Forero, L; Hammond, LA; Izbicka, E; Mita, AC; Mita, MM; Patnaik, A; Rowinsky, EK; Simmons, P; Takimoto, C; Tolcher, AW; Weiss, GR | 1 |
| Bertorelli, R; Burnett, DA; Domalski, M; Fredduzzi, S; Greenlee, WJ; Li, C; Lozza, G; Reggiani, A; Veltri, A; Wu, WL | 1 |
| Wehmeier, T; Ziajka, PE | 1 |
| Couri, D; Milks, MM | 1 |
| Asmal, AC; Joubert, SM; Vinik, AI | 1 |
1 review(s) available for pyrroles and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Peripheral neuropathy and lipid-lowering therapy.
Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Naphthalenes; Niacin; Peripheral Nervous System Diseases; Pravastatin; Pyrroles; Simvastatin | 1998 |
3 trial(s) available for pyrroles and Peripheral Nerve Diseases
| Article | Year |
|---|---|
The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Topics: Adult; Aged; Analgesia; Anesthetics, Local; Chronic Disease; Cross-Over Studies; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Hyperalgesia; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Pyrroles; Receptors, AMPA; Receptors, Kainic Acid; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Young Adult | 2009 |
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Glycine; Glycine Agents; Hot Temperature; Humans; Indoles; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Pyrroles; Sensory Thresholds; Treatment Outcome | 2002 |
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Area Under Curve; Asthenia; Dose-Response Relationship, Drug; Edema; Female; Half-Life; Headache; Humans; Indoles; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Peripheral Nervous System Diseases; Protein Kinase Inhibitors; Pyrroles; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Venous Thrombosis | 2007 |
12 other study(ies) available for pyrroles and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Diabetes mellitus is associated with elevated urinary pyrrole markers of γ-diketones known to cause axonal neuropathy.
Topics: Aged; Aged, 80 and over; Axons; China; Diabetes Mellitus; Humans; Middle Aged; Peripheral Nervous System Diseases; Pyrroles | 2020 |
Tofacitinib and Risk of Peripheral Neuropathy? Experience of 2 Cases in Patients With Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Peripheral Nervous System Diseases; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome | 2021 |
Hair pyrrole adducts serve as biomarkers for peripheral nerve impairment induced by 2,5-hexanedione and n-hexane in rats.
Topics: Animals; Biomarkers; Hair; Hexanes; Hexanones; Male; Peripheral Nervous System Diseases; Pyrroles; Rats; Rats, Wistar | 2018 |
The role of spinal thrombin through protease-activated receptor 1 in hyperalgesia after neural injury.
Topics: Animals; Antithrombins; Capillary Permeability; Central Nervous System Agents; Cervical Vertebrae; Disease Models, Animal; Fibrin; Hirudins; Hyperalgesia; Injections, Spinal; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pyrroles; Quinazolines; Radiculopathy; Rats, Sprague-Dawley; Receptor, PAR-1; Spinal Cord | 2017 |
Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Dedifferentiation; Combined Modality Therapy; Female; Humans; Hypothyroidism; Indoles; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nephrectomy; Peripheral Nervous System Diseases; Protein Kinase Inhibitors; Pyrroles; Remission Induction; Rhabdoid Tumor; Sunitinib | 2011 |
TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism.
Topics: Acetanilides; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cold Temperature; Drug Hypersensitivity; Glutathione; Hyperalgesia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Paclitaxel; Peripheral Nervous System Diseases; Purines; Pyrroles; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2012 |
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14.
Topics: Animals; Apoptosis; Autophagy; Cellular Senescence; Colonic Neoplasms; HCT116 Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Microtubules; Peripheral Nervous System Diseases; Pyrroles | 2013 |
Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Excitatory Amino Acid Antagonists; Male; Morphine; Narcotics; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Kainic Acid; Tetrahydroisoquinolines; Time Factors | 2004 |
Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
Topics: Analgesics; Animals; Area Under Curve; Chronic Disease; Heterocyclic Compounds, 4 or More Rings; Humans; Indazoles; Morpholines; Pain; Peripheral Nervous System Diseases; Pyridines; Pyrroles; Rats; Receptors, Metabotropic Glutamate; Structure-Activity Relationship | 2007 |
Peripheral neuropathy due to statins.
Topics: Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Naphthalenes; Peripheral Nervous System Diseases; Pyrroles | 2000 |
Hexacarbon neuropathy: tracking a toxin.
Topics: Animals; Biotransformation; Hexanes; Hexanones; Humans; Intermediate Filament Proteins; Isomerism; Ketones; Methyl n-Butyl Ketone; Neurofilament Proteins; Occupational Diseases; Peripheral Nervous System Diseases; Pyrroles; Rats; Textile Industry | 1985 |
A neurological disorder in porphyria cutanea tarda.
Topics: Adult; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Female; Glucose; Humans; Iron; Levulinic Acids; Liver Cirrhosis; Male; Middle Aged; Peripheral Nervous System Diseases; Porphyrias; Porphyrins; Propionates; Pyrroles; Serum Albumin | 1970 |